Substance use before or during pregnancy and the risk of child mortality, perinatal morbidities and congenital anomalies

CONCLUSIONS: Increased risks of child mortality, perinatal morbidities or congenital anomalies were found in women with substance use during pregnancy. From estimates before and after adjustments, our results showed that having outpatient visits or medical utilizations during pregnancy were associated with substantially attenuated HRs on mortality in the substance-exposed cohort. Therefore, the excess mortality risk might be partially explained by the lack of relevant antenatal clinical care. Our finding may suggest that the importance of early identification, specific abstinence program and access to appropriate antenatal care might be helpful in reducing newborn mortality. Adequate prevention policies may be formulated.PMID:37431291 | DOI:10.1017/S2045796023000549

Source: Epidemiology and Psychiatric Sciences - July 11, 2023 Category: Psychiatry Authors: Charles Tzu-Chi Lee Vincent Chin-Hung Chen Johnny Kuang-Wu Lee Shu-I Wu Gillian Cheng Tzu-Min Kao Shih-Yuan Wang Michael Gossop Source Type: research